Switch to:

10x Genomics Additional Paid-In Capital

: $692.6 Mil(As of Mar. 2020)
View and export this data going back to 2019. Start your Free Trial

10x Genomics's quarterly additional paid-in capital increased from Sep. 2019 ($676.8 Mil) to Dec. 2019 ($682.5 Mil) and increased from Dec. 2019 ($682.5 Mil) to Mar. 2020 ($692.6 Mil).

10x Genomics's annual additional paid-in capital increased from Dec. 2017 ($6.1 Mil) to Dec. 2018 ($11.2 Mil) and increased from Dec. 2018 ($11.2 Mil) to Dec. 2019 ($682.5 Mil).


10x Genomics Additional Paid-In Capital Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

10x Genomics Annual Data
Dec17 Dec18 Dec19
Additional Paid-In Capital 6.14 11.17 682.49

10x Genomics Quarterly Data
Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Additional Paid-In Capital Premium Member Only Premium Member Only Premium Member Only 0.00 260.96 676.84 682.49 692.62

10x Genomics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

10x Genomics Additional Paid-In Capital Related Terms


10x Genomics Additional Paid-In Capital Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)